Ozempic and GLP-1 Medications While Breastfeeding: Are They Safe?
Updated: Sep 29
What the research says about semaglutide, tirzepatide, milk supply, maternal nutrition and natural ways to support GLP-1 while breastfeeding.
By Marina Lane, MS, RD, CLC
The short answer: Early human research suggests that very little, if any, injectable semaglutide or tirzepatide reaches breast milk. But milk transfer is only one piece of the safety question. The bigger question is: How does reduced appetite and food intake affect breast milk supply, quality and postpartum recovery? Whether or not you can take Ozempic or another GLP-1 while breastfeeding may actually depend on baby's age, development and whether or not the benefits outweigh the risks in your specific situation.
If losing weight while breastfeeding has felt much harder than expected, you may be wondering whether Ozempic or another GLP-1 medication could help. You may also be asking: Does it pass into breast milk? Could it reduce milk supply? Is it safe for my baby?
Early research suggests that very little injectable semaglutide or tirzepatide passes into breast milk. That is reassuring, but milk transfer is only part of the safety question. We also need to consider appetite suppression, maternal nutrition, hydration, milk production, baby’s age, and talk about the risk vs. benefit equation.
Can You Take Ozempic or Another GLP-1 While Breastfeeding?
We do not yet have enough research to say that GLP-1 medications are safe for every breastfeeding mother and baby.
Small studies suggest that direct infant exposure to injectable semaglutide and tirzepatide through breast milk is likely very low. However, those studies did not adequately evaluate exclusively breastfed newborns, long-term treatment, higher doses, milk production, or long-term infant development. [1-4]
The decision may therefore look very different for a mother exclusively breastfeeding a newborn than for a mother nursing a thriving toddler once or twice per day.
If the medication is needed to treat type 2 diabetes, obesity, or another significant health condition, the potential benefits may also outweigh the uncertainties in some situations. That decision should be made individually with the mother’s prescriber and the baby’s healthcare provider.
Do GLP-1 Medications Pass Into Breast Milk?
Semaglutide: Ozempic and Wegovy
In a small 2024 study, injectable semaglutide was not detected in any of the 24 breast-milk samples collected from eight mothers. The mothers also reported no concerns about their infants’ growth or development during the brief study period. [1,2]
However, the children were between 4 and 23 months old and received foods or formula in addition to breast milk (mixed-fed). The study did not include exclusively breastfed newborns or evaluate long-term outcomes.
Tirzepatide: Mounjaro and Zepbound
Early research on tirzepatide has produced similarly encouraging results. Tirzepatide was undetectable in most breast-milk samples and was present only in very small amounts in the remaining samples. [3,4]
Still, these studies included very few women. One manufacturer-sponsored study also tested only a single 5-milligram dose, which cannot tell us whether medication might accumulate in milk after months of weekly treatment.
The evidence so far is encouraging, but it is not definitive proof of safety in every breastfeeding situation.
Could GLP-1 Medications Reduce Milk Supply
We do not currently have evidence that semaglutide or tirzepatide directly suppresses the hormones responsible for milk production.
My larger concern as a registered dietitian and lactation counselor is the medications’ powerful effect on appetite.
GLP-1 medications may cause:
Significant appetite suppression
Nausea, vomiting, diarrhea, or constipation
Food aversions
Dehydration
Rapid weight loss
Difficulty consuming enough calories, protein, and other nutrients
Any of these effects could indirectly reduce milk production, especially during the early postpartum months, while milk supply is still being established or when a baby depends almost entirely on breast milk. [5-8]
An occasional low-intake day will not suddenly destroy a well-established milk supply. However, prolonged under-eating, dehydration, rapid weight loss, or less frequent milk removal may create problems.
Use my free Breastfeeding Calorie Calculator to estimate your individual calorie and macronutrient needs.
What About Breastfeeding an Older Baby or Toddler?
The risk-benefit discussion may change when breastfeeding an older baby or toddler.
During the first year, breast milk or infant formula is still the major source of nutrition. Newborns and young infants may also be more vulnerable to medication exposure, and maintaining good nutrition and milk production is especially important during this period.
For these reasons, I would not recommend beginning a GLP-1 medication solely for weight loss while exclusively breastfeeding a newborn or while a younger baby still depends heavily on breast milk.
After the first year, a thriving toddler may eat regular meals and snacks and nurse only a few times per day. Although breast milk still provides valuable nutrition and immune support, it may no longer be the child’s primary source of calories. [10]
This does not mean that GLP-1 medications automatically become safe on a child’s first birthday. Twelve months is not a research-established safety cutoff. However, the potential consequences of reduced milk production or very small medication exposure may be different when breastfeeding is no longer your child’s main source of nutrition.
The decision should consider:
Your child’s age, health, and growth
Whether your child was born prematurely
How frequently your child breastfeeds
How much nutrition your child receives from food or formula
Whether your milk supply is well established
Your nutritional status
The reason the medication is needed (What is the risk of not taking it?)
Whether you can eat and drink adequately during treatment
Are Oral GLP-1 Medications Different?
Yes. Oral and injectable semaglutide should not automatically be treated as interchangeable during breastfeeding.
Some oral semaglutide products contain an absorption enhancer called SNAC. Its breakdown products may enter breast milk and accumulate in an infant. Current LactMed guidance recommends using injectable rather than oral semaglutide during breastfeeding when semaglutide is considered appropriate. [2,11]
This includes oral semaglutide products marketed under names such as Rybelsus or oral Wegovy.
Is Microdosing a Safer Option While Breastfeeding?
“Microdosing” generally refers to taking less than the standard starting dose or dividing the medication into smaller doses. There is no standardized, FDA-approved microdosing schedule for semaglutide or tirzepatide, and microdosing has not been studied in breastfeeding mothers or infants.
A smaller dose might produce fewer side effects, but that does not make it proven safe. The medication may still suppress appetite, and dosing outside approved products and schedules may increase the risk of dosing errors, particularly when compounded or unapproved products are used. [12]
My Recommendations for Moms Considering a GLP-1 While Breastfeeding
If your primary goal is postpartum weight loss:
My recommendation is to begin with safer, food-based ways to support your body’s natural GLP-1 production rather than using a GLP-1 medication while your baby still depends heavily on breast milk.
Your body already makes GLP-1 in the gut after you eat. Food will not produce the same "quick weight loss" effect as Ozempic, Wegovy, or Mounjaro, but can lead to longer-lasting, sustainable ways to support your natural fullness signals, reduce blood sugar swings, and make postpartum hunger feel more manageable, without the side effects or lifelong reliance on medication. [13]
Foods That Support Natural GLP-1 Production
Food has a gentler, shorter-lasting effect than GLP-1 medication, but certain foods may naturally support GLP-1 release and fullness:
Protein-rich foods: Eggs, Greek yogurt, fish, poultry, tofu, beans, and lentils. [12]
Fermentable fiber: Oats, barley, beans, lentils, and chia seeds. [13-16]
Resistant starch: Slightly green bananas and cooked-and-cooled potatoes, rice, or pasta. [12,13]
Healthy fats: Olive oil, avocado, nuts, seeds, eggs, and fatty fish. [12]
Try combining protein, fiber, and healthy fat at meals to support fullness, steady energy, and gradual weight loss.
If a GLP-1 medication is medically necessary:
Sometimes, the benefits may outweigh the risks. If your primary care provider determines a GLP-1 medication is necessary to treat obesity, type 2 diabetes, or another signficant health condition, discuss the risks while breastfeeding with your prescriber. Your baby’s age, dependence on breast milk, growth, your milk supply, and your ability to meet your nutritional needs should all be part of that conversation.
My personal recommendation is to avoid using a GLP-1 medication for weight loss while breastfeeding a baby under one year of age. If you are breastfeeding an older baby or toddler, the decision may be different and should be made individually with a licensed healthcare provider you trust.
Want practical help losing weight without compromising your nutrition or milk supply? Join the TLNourish app for breastfeeding-friendly weight-loss guidance created by a registered dietitian and lactation counselor.
The Bottom Line
Early research suggests that very little injectable semaglutide or tirzepatide passes into breast milk. However, the studies are small and do not fully answer questions about exclusively breastfed newborns, long-term treatment, higher doses, milk production, or long-term infant health.
I would not recommend beginning a GLP-1 medication solely for weight loss while breastfeeding a newborn or younger baby who depends heavily on breast milk. There are safer, more sustainable ways to increase your natural GLP-1 production through diet,
The decision may be different for a mother nursing an older child when the medication is needed to treat obesity, type 2 diabetes, or another significant health condition. In that situation, the benefits and uncertainties should be discussed individually with qualified healthcare providers.
IMPORTANT REMINDER! (Please read):
A GLP-1 Does Not Replace Good Nutrition
A GLP-1 medication may help you eat less, but eating less does not automatically mean eating better. This is especially important after pregnancy and while breastfeeding, when your body may already be working to rebuild nutrient stores.
Because these medications can greatly reduce appetite, it becomes even more important to make every meal count. Without enough protein, vitamins, minerals, fiber, healthy fats, and fluids, you may lose muscle, feel more tired, become constipated or dehydrated, and struggle to meet your body’s needs.
A GLP-1 should be viewed as a tool, but not the entire plan. Nourishing meals, strength-building movement, and healthy habits still matter, regardless of what the scale says.
Frequently Asked Questions
Can I take GLP-1 while breastfeeding?
My personal recommendation is to not take Ozempic or any other GLP-1 while breastfeeding a baby under 1 year of age. Moms breastfeeding older babies (>1 year of age) who get most of their calories from food should weigh the risk and benefits of GLP-1s with their healthcare providers.
Does GLP-1 pass into breast milk?
The studies we have so far suggest that very little, if any, injected GLP-1 passes into breast milk. However, more studies are needed to confirm this.
Can GLP-1 medications reduce milk supply?
Possibly. These medications can substantially reduce appetite and cause nausea, vomiting, diarrhea, constipation, and food aversions. If these effects lead to significant under-eating, dehydration, or rapid weight loss, it could reduce your milk supply significantly, especially in the first months postpartum.
Are oral GLP-1 medications safe while breastfeeding?
Oral and injectable semaglutide should not automatically be treated as interchangeable during breastfeeding. Some oral semaglutide products contain an absorption enhancer called SNAC, whose breakdown products may enter breast milk and accumulate in an infant. Current LactMed guidance recommends using only injectable, not oral, semaglutide during breastfeeding. [2]
Is microdosing a GLP-1 safer while breastfeeding?
Microdosing has not been studied in breastfeeding mothers or infants, and there is no standardized or FDA-approved microdosing schedule for semaglutide or tirzepatide. At this time, it does not seem to be a safer alternative to standard GLP-1 injections.
Is it safe to take a GLP-1 while breastfeeding an older child?
The risk-benefit discussion changes a bit when breastfeeding a thriving toddler who receives most of their nutrition from food and nurses only a few times per day. The decision to take GLP-1 while nursing a child over the age of 1 should consider the child’s health and growth, nursing frequency, the mother’s milk supply and nutritional status, and the medical reason for treatment. This can be discussed with your trusted healthcare provider.
Can I take a GLP-1 while exclusively breastfeeding a newborn?
The available human studies did not include exclusively breastfed newborns, and newborns depend heavily on breast milk for nutrition. They may also be more vulnerable to medication exposure than older infants. Because of these uncertainties, and the importance of protecting maternal nutrition and establishing milk supply, I do not recommend beginning a GLP-1 medication solely for weight loss while exclusively breastfeeding a newborn.
What should be monitored if I take a GLP-1 while breastfeeding?
Work with your healthcare provider to monitor your food and fluid intake, rate of weight loss, digestive side effects, nutritional status, and milk production. Your baby’s growth, feeding behavior, hydration, and overall health should also be followed. Contact your healthcare provider if you experience persistent vomiting or diarrhea, cannot eat or drink adequately, notice a substantial decrease in milk production, or have concerns about your baby’s feeding or growth.
Are there foods that naturally increase GLP-1?
Eating naturally causes the intestines to release GLP-1 and other hormones involved in fullness and blood-sugar control. Protein-rich foods appear to produce the clearest GLP-1 response, while fiber-rich carbohydrates and healthy fats may also support the body’s normal appetite signals. Examples include eggs, Greek yogurt, fish, poultry, tofu, beans, lentils, oats, vegetables, nuts, seeds, avocado, and olive oil. Several foods are currently being studied as potentially having an "Ozempic-like" effect, although no single food will have as strong as an effect as a medication will have.
I just can't lose weight while breastfeeding, despite doing everything 'right'. What do I do?
As a postpartum nutritionist, I hear this complaint a lot. Moms seemingly do everything 'by the book', and still can't lose weight, or even gain weight. Studies have shown, some people may have altered GLP-1 and other hunger/satiety hormone biology. Their GLP-1 rise after eating may be smaller compared to people who have an easier time losing weight and controling their appetite.
About the Author
Marina Lane, MS, RD, CLC, is a registered dietitian, certified lactation counselor, and founder of The Lactation Nutritionist and the TLNourish app. She has helped hundreds of breastfeeding mothers navigate postpartum nutrition, weight loss, and milk-supply concerns using practical, evidence-informed guidance.
References
Diab H, Fuquay T, Datta P, Bickel U, Thompson J, Krutsch K. Subcutaneous semaglutide during breastfeeding: Infant safety regarding drug transfer into human milk. Nutrients. 2024;16(17):2886. doi:10.3390/nu16172886
National Library of Medicine. Semaglutide. Drugs and Lactation Database (LactMed®). National Institute of Child Health and Human Development. Revised August 15, 2026. View the LactMed entry
National Library of Medicine. Tirzepatide. Drugs and Lactation Database (LactMed®). National Institute of Child Health and Human Development. Revised August 15, 2026. View the LactMed entry
Eli Lilly and Company. Mounjaro® (tirzepatide) injection: U.S. prescribing information. Revised August 2026. See Section 8.2, Lactation. View prescribing information
Novo Nordisk. Wegovy® (semaglutide) injection and tablets: U.S. prescribing information. Revised 2026. See Sections 5, 6, and 8.2. View FDA prescribing information
Eli Lilly and Company. Zepbound® (tirzepatide) injection: U.S. prescribing information. Revised 2026. See Sections 5, 6, and 8.2. View prescribing information
Centers for Disease Control and Prevention. Maternal diet and breastfeeding. Updated August 25, 2026. View CDC guidance
Dewey KG. Effects of maternal caloric restriction and exercise during lactation. Journal of Nutrition. 1998;128(2 Suppl):386S–389S. doi:10.1093/jn/128.2.386S
World Health Organization. Infant and young child feeding. Updated August 4, 2026. View WHO guidance
Novo Nordisk. Wegovy® tablets and injection: U.S. prescribing information. Revised 2026. See Section 8.2 for lactation information concerning tablets containing salcaprozate sodium, or SNAC. View FDA prescribing information
U.S. Food and Drug Administration. FDA’s concerns with unapproved GLP-1 drugs used for weight loss. Updated September 2026. View FDA safety information
Huber H, Schieren A, Holst JJ, Simon MC. Dietary impact on fasting and stimulated GLP-1 secretion in different metabolic conditions-a narrative review. American Journal of Clinical Nutrition. 2024;119(3):599–627. doi:10.1016/j.ajcnut.2024.01.007
de Jong JCBC, Lentjes MGW, Pietersma KF, Pasman WJ, Wopereis S, Hoevenaars FPM. Dietary fibers to boost endogenous GLP-1 secretion and satiety: A scoping review. Frontiers in Endocrinology. 2026;17:1880500. doi:10.3389/fendo.2026.1880500
Chen C, Huang X, Wang H, Geng F, Nie S. Effect of β-glucan on metabolic diseases: A review from the gut microbiota perspective. Current Opinion in Food Science. 2022;47:100907. doi:10.1016/j.cofs.2022.100907
Shehzad A, Rabail R, Munir S, Jan H, Fernández-Lázaro D, Aadil RM. Impact of oats on appetite hormones and body weight management: A review. Current Nutrition Reports. 2023;12:66–82. doi:10.1007/s13668-023-00454-3
Matondo JD, Abihudi SA. Chia seeds: A nutrient-dense functional food for health and nutrition. Cogent Food & Agriculture. 2026;12(1):2626606. doi:10.1080/23311932.2026.2626606
Leidy HJ, Clifton PM, Astrup A, et al. The role of protein in weight loss and maintenance. American Journal of Clinical Nutrition. 2015;101(6):1320S–1329S. doi:10.3945/ajcn.114.084038
Cava E, Yeat NC, Mittendorfer B. Preserving healthy muscle during weight loss. Advances in Nutrition. 2017;8(3):511–519. doi:10.3945/an.116.014506
